AquaBounty Technologies (AQB) Expected to Announce Quarterly Earnings on Tuesday

AquaBounty Technologies (NASDAQ:AQB) is expected to be posting its results before the market opens on Tuesday, March 10th. Analysts expect AquaBounty Technologies to post earnings of ($0.52) per share and revenue of $0.50 million for the quarter.

AquaBounty Technologies Trading Down 0.3%

NASDAQ:AQB opened at $0.93 on Monday. The firm has a market cap of $3.60 million, a PE ratio of -1.12 and a beta of 1.29. The stock has a fifty day moving average price of $0.93 and a 200 day moving average price of $1.15. AquaBounty Technologies has a 12-month low of $0.50 and a 12-month high of $2.95.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of AquaBounty Technologies in a report on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Institutional Investors Weigh In On AquaBounty Technologies

A hedge fund recently bought a new stake in AquaBounty Technologies stock. Two Sigma Investments LP bought a new position in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 37,565 shares of the company’s stock, valued at approximately $84,000. Two Sigma Investments LP owned about 0.97% of AquaBounty Technologies as of its most recent SEC filing. 8.92% of the stock is currently owned by institutional investors and hedge funds.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.